Atomo Diagnostics Ltd

NEW
ASX:AT1 (Australia)   Ordinary Shares
A$ 0.017 -0.0010 (-5.56%) Mar 28
At Loss
P/B:
1.41
Market Cap:
A$ 10.87M ($ 6.85M)
Enterprise V:
A$ 8.17M ($ 5.15M)
Volume:
78.57K
Avg Vol (2M):
286.33K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
78.57K
At Loss
Avg Vol (2M):
286.33K

Business Description

Description
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 14.55
Equity-to-Asset 0.8
Debt-to-Equity 0.03
Debt-to-EBITDA -0.04
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.71
Distress
Grey
Safe
Beneish M-Score -3.37
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 31.9
9-Day RSI 39.3
14-Day RSI 42.14
3-1 Month Momentum % -7.69
6-1 Month Momentum % -5.26
12-1 Month Momentum % -41.94

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.5
Quick Ratio 2.44
Cash Ratio 1.71
Days Inventory 257.75
Days Sales Outstanding 113.99
Days Payable 90.75

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -4
Shareholder Yield % 2.07

Financials

ASX:AT1's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Atomo Diagnostics Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 4.055
EPS (TTM) (A$) -0.01
Beta 1.64
3-Year Sharpe Ratio -1.1
3-Year Sortino Ratio -1.36
Volatility % 28.79
14-Day RSI 42.14
14-Day ATR (A$) 0.000923
20-Day SMA (A$) 0.017925
12-1 Month Momentum % -41.94
52-Week Range (A$) 0.016 - 0.044
Shares Outstanding (Mil) 639.2

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Atomo Diagnostics Ltd Filings

Filing Date Document Date Form
No Filing Data

Atomo Diagnostics Ltd Stock Events

Financials Calendars
Event Date Price (A$)
No Event Data

Atomo Diagnostics Ltd Frequently Asked Questions

What is Atomo Diagnostics Ltd(ASX:AT1)'s stock price today?
The current price of ASX:AT1 is A$0.02. The 52 week high of ASX:AT1 is A$0.04 and 52 week low is A$0.02.
When is next earnings date of Atomo Diagnostics Ltd(ASX:AT1)?
The next earnings date of Atomo Diagnostics Ltd(ASX:AT1) is .
Does Atomo Diagnostics Ltd(ASX:AT1) pay dividends? If so, how much?
Atomo Diagnostics Ltd(ASX:AT1) does not pay dividend.

Press Release

Subject Date
No Press Release